Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Accenture
Colorcon
US Department of Justice
Fish and Richardson

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 8,956,830

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,956,830
Title:Methods of cell culture
Abstract: Polypeptide preparations having target levels of glycans, and methods of producing such polypeptide preparations using DMSO, are described.
Inventor(s): Prentice; Holly (Carlisle, MA), Tijani; Rasheed (Haverhill, MA), Belongia; Brett (North Andover, MA)
Assignee: Momenta Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:13/829,292
Patent Claims:see list of patent claims

Details for Patent 8,956,830

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Sign Up Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2036-04-30 RX search
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Sign Up Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2036-04-30 RX search
Bristol Myers Squibb NULOJIX belatacept INJECTABLE; INJECTION 125288 001 2011-06-15 ➤ Sign Up Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2036-04-30 RX search
Regeneron Pharmaceuticals ARCALYST rilonacept VIAL; SINGLE-USE 125249 001 2008-02-27 ➤ Sign Up Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2036-04-30 RX Orphan search
Alexion Pharm SOLIRIS eculizumab INJECTABLE; IV (INFUSION) 125166 001 2007-03-16 ➤ Sign Up Momenta Pharmaceuticals, Inc. (Cambridge, MA) 2036-04-30 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cipla
Argus Health
Healthtrust
Federal Trade Commission
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.